Ledger.Open graph →
SEC Form D · filed December 30, 2011

Pulse Therapeutics, Inc

Offering
$3.1M
Sold
$3.1M
Exemption
—
Industry
Biotechnology
Location
ST. LOUIS, MO
Type
—

People & firms on this filing (15)

Francis M. Creighton · St. Louis, MOExec · DirectorPeggy Stohr · St. Louis, MOExecThomas J. Hillman · St. Louis, MODirectorStephen A. Wexler · St. Louis, MODirectorRogers Ritter · St. Louis, MOExecBevil J. Hogg · St. Louis, MODirectorDaniel J. Broderick · St. Louis, MODirectorRobert Ketterson · Boston, MAExecMartin Hall · Cupertino, CAExec · DirectorAnn Winblad · Cupertino, CAExecDavid Liddle · Cupertino, CADirectorDebby Meredith · Cupertino, CADirectorDaniel Moskowitz · Cupertino, CADirectorCorey S. Johnson · Nashville, TNDirectorJames C. Wachtman · St. Louis, MOExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗